[1] Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C. Early-onset Alzheimer's disease:what is missing in research[J]? Curr Neurol Neurosci Rep, 2021, 21:4. [2] Uddin MS, Hasana S, Hossain MF, Islam MS, Behl T, Perveen A, Hafeez A, Ashraf GM. Molecular genetics of early-and late-onset Alzheimer's disease[J]. Curr Gene Ther, 2021, 21:43-52. [3] Xiao X, Liu H, Liu X, Zhang W, Zhang S, Jiao B. APP, PSEN1, and PSEN2 variants in Alzheimer's disease:systematic re-evaluation according to ACMG guidelines[J]. Front Aging Neurosci, 2021, 13:695808. [4] Zhang MY. Manual of the psychiatric rating scale[M]. Changsha:Hu'nan Science and Technology Press, 1998.[张明园. 精神科评定量表手册[M]. 长沙:湖南科学技术出版社, 1998.] [5] Lu J, Li D, Li F, Zhou A, Wang F, Zuo X, Jia XF, Song H, Jia J. Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals:a population-based study[J]. J Geriatr Psychiatry Neurol, 2011, 24:184-190. [6] Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L. Cerebral blood flow in dementia[J]. Arch Neurol, 1975, 2:632-637. [7] Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin CL. Technical standards for the interpretation and reporting of constitutional copy-number variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)[J]. Genet Med, 2020, 22:245-257. [8] Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert MO, Nordberg A, Blennow K, Galasko D, Stern Y, Rowe CC, Salloway S, Schneider LS, Cummings JL, Feldman HH. Clinical diagnosis of Alzheimer's disease:recommendations of the International Working Group[J]. Lancet Neurol, 2021, 20:484-496. [9] Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer's disease:advances in genetics, pathophysiology, and therapeutic approaches[J]. Lancet Neurol, 2021, 20:68-80. [10] Youn YC, Bagyinszky E, Kim H, Choi BO, An SS, Kim S. Probable novel PSEN2 Val214Leu mutation in Alzheimer's disease supported by structural prediction[J]. BMC Neurol, 2014, 14:105. [11] Shi Z, Wang Y, Liu S, Liu M, Liu S, Zhou Y, Wang J, Cai L, Huo YR, Gao S, Ji Y. Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations[J]. Dement Geriatr Cogn Disord, 2015, 39:32-40. [12] An SS, Park SA, Bagyinszky E, Bae SO, Kim YJ, Im JY, Park KW, Park KH, Kim EJ, Jeong JH, Kim JH, Han HJ, Choi SH, Kim S. A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease[J]. Clin Interv Aging, 2016, 11:1817-1822. [13] Gao Y, Wang G, Ren RJ. Familial Alzheimer's disease caused by PSEN2 mutation:one case report[J]. Chongqing Yi Ke Da Xue Xue Bao, 2017, 42:731-732.[高颖, 王刚, 任汝静. PSEN2突变引起的家族性阿尔茨海默病1例报道[J]. 重庆医科大学学报, 2017, 42:731-732.] [14] Xu Y, Liu X, Shen J, Tian W, Fang R, Li B, Ma J, Cao L, Chen S, Li G, Tang H. The whole exome sequencing clarifies the genotype-phenotype correlations in patients with early-onset dementia[J]. Aging Dis, 2018, 9:696-705. [15] Giau VV, Bagyinszky E, Youn YC, An SSA, Kim S. APP, PSEN1, and PSEN2 mutations in Asian patients with early-onset Alzheimer disease[J]. Int J Mol Sci, 2019, 20:4757. [16] Jia L, Fu Y, Shen L, Zhang H, Zhu M, Qiu Q, Wang Q, Yan X, Kong C, Hao J, Wei C, Tang Y, Qin W, Li Y, Wang F, Guo D, Zhou A, Zuo X, Yu Y, Li D, Zhao L, Jin H, Jia J. PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer's disease[J]. Alzheimers Dement, 2020, 16:178-191. [17] Jiang QW, Tang HD. Sporadic Alzheimer's disease caused by PSEN2 gene mutation:one case report[J]. A Er Ci Hai Mo Bing Ji Xiang Guan Bing Za Zhi, 2021, 4:302-305.[蒋倩雯, 汤荟冬. PSEN2基因突变所致的散发性阿尔茨海默病1 例报告[J]. 阿尔茨海默病及相关病杂志, 2021, 4:302-305.] [18] Liang Z, Wu Y, Li C, Liu Z. Clinical and genetic characteristics in a central-southern Chinese cohort of early-onset Alzheimer's disease[J]. Front Neurol, 2023, 14:1119326. [19] De Marothy MT, Elofsson A. Marginally hydrophobic transmembrane α-helices shaping membrane protein folding[J]. Protein Sci, 2015, 24:1057-1074. [20] Tang S, Li J, Huang G, Yan L. Predicting protein surface property with its surface hydrophobicity[J]. Protein Pept Lett, 2021, 28:938-944. [21] Aryal P, Sansom MS, Tucker SJ. Hydrophobic gating in ion channels[J]. J Mol Biol, 2015, 427:121-130. [22] Hsu S, Pimenova AA, Hayes K, Villa JA, Rosene MJ, Jere M, Goate AM, Karch CM. Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2[J]. Neurobiol Dis, 2020, 139:104817. [23] Koriath C, Kenny J, Adamson G, Druyeh R, Taylor W, Beck J, Quinn L, Mok TH, Dimitriadis A, Norsworthy P, Bass N, Carter J, Walker Z, Kipps C, Coulthard E, Polke JM, Bernal-Quiros M, Denning N, Thomas R, Raybould R, Williams J, Mummery CJ, Wild EJ, Houlden H, Tabrizi SJ, Rossor MN, Hummerich H, Warren JD, Rowe JB, Rohrer JD, Schott JM, Fox NC, Collinge J, Mead S. Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series[J]. Mol Psychiatry, 2020, 25:3399-3412. [24] Barthelson K, Newman M, Lardelli M. Sorting out the role of the sortilin-related receptor 1 in Alzheimer's disease[J]. J Alzheimers Dis Rep, 2020, 4:123-140. [25] Yin RH, Yu JT, Tan L. The Role of SORL1 in Alzheimer's Disease[J]. Mol Neurobiol, 2015, 51:909-918. [26] Spoelgen R, von Arnim CA, Thomas AV, Peltan ID, Koker M, Deng A, Irizarry MC, Andersen OM, Willnow TE, Hyman BT. Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme[J]. J Neurosci, 2006, 26:418-428. [27] Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM. Alzheimer's disease[J]. Lancet, 2021, 397:1577-1590. [28] Schramm C, Charbonnier C, Zaréa A, Lacour M, Wallon D, Boland A, Deleuze JF, Olaso R, Alarcon F, Campion D, Nuel G, Nicolas G; CNRMAJ Collaborators, ADES Consortium. Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes[J]. Genome Med, 2022, 14:69. |